
Dale R. Miller
Examiner (ID: 5360, Phone: (571)272-6146 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1673, 1693 |
| Total Applications | 838 |
| Issued Applications | 502 |
| Pending Applications | 84 |
| Abandoned Applications | 276 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16761028
[patent_doc_number] => 20210106609
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-04-15
[patent_title] => HEALTH SUPPLEMENT
[patent_app_type] => utility
[patent_app_number] => 17/070810
[patent_app_country] => US
[patent_app_date] => 2020-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13452
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 69
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17070810
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/070810 | Health supplement | Oct 13, 2020 | Issued |
Array
(
[id] => 16596524
[patent_doc_number] => 20210023055
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-28
[patent_title] => MOFEZOLAC DERIVATIVES AS MULTI-FUNCTIONS SELECTIVE COX-1 INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/062269
[patent_app_country] => US
[patent_app_date] => 2020-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16423
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17062269
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/062269 | Mofezolac derivatives as multi-functions selective COX-1 inhibitors | Oct 1, 2020 | Issued |
Array
(
[id] => 16671293
[patent_doc_number] => 20210060056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-04
[patent_title] => OPHTHALMIC COMPOSITIONS WITH IMPROVED DESSICATION PROTECTION AND RETENTION
[patent_app_type] => utility
[patent_app_number] => 17/060343
[patent_app_country] => US
[patent_app_date] => 2020-10-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3467
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17060343
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/060343 | Ophthalmic compositions with improved dessication protection and retention | Sep 30, 2020 | Issued |
Array
(
[id] => 18056377
[patent_doc_number] => 20220387463
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => TREHALOSE FORMULATIONS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/765059
[patent_app_country] => US
[patent_app_date] => 2020-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24193
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17765059
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/765059 | Trehalose formulations and uses thereof | Sep 28, 2020 | Issued |
Array
(
[id] => 18280229
[patent_doc_number] => 20230095701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => Use of Albiflorin in Treatment of Coronavirus Pneumonia
[patent_app_type] => utility
[patent_app_number] => 17/802806
[patent_app_country] => US
[patent_app_date] => 2020-09-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17802806
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/802806 | Use of Albiflorin in Treatment of Coronavirus Pneumonia | Sep 24, 2020 | Abandoned |
Array
(
[id] => 16686760
[patent_doc_number] => 20210069235
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-11
[patent_title] => COMPOSITION FOR TREATING JOINT DISEASE AND KIT CONTAINING SAME
[patent_app_type] => utility
[patent_app_number] => 17/026910
[patent_app_country] => US
[patent_app_date] => 2020-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13188
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17026910
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/026910 | Composition for treating joint disease and kit containing same | Sep 20, 2020 | Issued |
Array
(
[id] => 16555820
[patent_doc_number] => 20210000968
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/024368
[patent_app_country] => US
[patent_app_date] => 2020-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28185
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17024368
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/024368 | ALGINIC ACID DERIVATIVE BONDED TO NONSTEROIDAL ANTI-INFLAMMATORY COMPOUND | Sep 16, 2020 | Abandoned |
Array
(
[id] => 16621584
[patent_doc_number] => 20210040237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-11
[patent_title] => NANO-CRYSTALLINE CELLULOSE
[patent_app_type] => utility
[patent_app_number] => 17/021066
[patent_app_country] => US
[patent_app_date] => 2020-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13237
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17021066
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/021066 | Nano-crystalline cellulose | Sep 14, 2020 | Issued |
Array
(
[id] => 16539436
[patent_doc_number] => 20200405849
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-31
[patent_title] => VACCINE SYSTEM FOR VACCINE ADJUVANT
[patent_app_type] => utility
[patent_app_number] => 17/018975
[patent_app_country] => US
[patent_app_date] => 2020-09-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5012
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17018975
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/018975 | VACCINE SYSTEM FOR VACCINE ADJUVANT | Sep 10, 2020 | Pending |
Array
(
[id] => 17944465
[patent_doc_number] => 20220331482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => Hydrogel Composition For Tissue Regeneration, And Support Prepared Using Same
[patent_app_type] => utility
[patent_app_number] => 17/763136
[patent_app_country] => US
[patent_app_date] => 2020-09-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4447
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -8
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17763136
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/763136 | Hydrogel Composition For Tissue Regeneration, And Support Prepared Using Same | Aug 31, 2020 | Abandoned |
Array
(
[id] => 16523864
[patent_doc_number] => 20200397944
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-12-24
[patent_title] => HYALURONIC ACID COMPOSITION FOR PENILE INJECTIONS
[patent_app_type] => utility
[patent_app_number] => 17/007533
[patent_app_country] => US
[patent_app_date] => 2020-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9013
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 74
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17007533
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/007533 | HYALURONIC ACID COMPOSITION FOR PENILE INJECTIONS | Aug 30, 2020 | Abandoned |
Array
(
[id] => 16555700
[patent_doc_number] => 20210000848
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-01-07
[patent_title] => SYNTHETIC COMPOSITION FOR MICROBIOTA MODULATION
[patent_app_type] => utility
[patent_app_number] => 17/001118
[patent_app_country] => US
[patent_app_date] => 2020-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9787
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17001118
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/001118 | Synthetic composition for microbiota modulation | Aug 23, 2020 | Issued |
Array
(
[id] => 16657378
[patent_doc_number] => 20210054014
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-25
[patent_title] => POLYMORPHIC FORMS OF DEOXYCYTIDINE, COMPOSITIONS COMPRISING THE SAME AND USES
[patent_app_type] => utility
[patent_app_number] => 16/997727
[patent_app_country] => US
[patent_app_date] => 2020-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10979
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 77
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16997727
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/997727 | Polymorphic forms of deoxycytidine, compositions comprising the same and uses | Aug 18, 2020 | Issued |
Array
(
[id] => 17805021
[patent_doc_number] => 20220256856
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => Antifungal composition comprising natamycin and at least one insecticide
[patent_app_type] => utility
[patent_app_number] => 17/630313
[patent_app_country] => US
[patent_app_date] => 2020-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17630313
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/630313 | Antifungal composition comprising natamycin and at least one insecticide | Aug 12, 2020 | Issued |
Array
(
[id] => 16712023
[patent_doc_number] => 20210079170
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-03-18
[patent_title] => PREPARATION METHOD OF 4D CHITOSAN-BASED THERMOSENSITIVE HYDROGEL
[patent_app_type] => utility
[patent_app_number] => 16/984626
[patent_app_country] => US
[patent_app_date] => 2020-08-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2808
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16984626
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/984626 | Preparation method of 4D chitosan-based thermosensitive hydrogel | Aug 3, 2020 | Issued |
Array
(
[id] => 18091308
[patent_doc_number] => 20220409649
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-29
[patent_title] => a-GLUCOSIDASE INHIBITOR, INVERTASE INHIBITOR, AND SUGAR ABSORPTION INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/633869
[patent_app_country] => US
[patent_app_date] => 2020-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 16
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17633869
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/633869 | a-GLUCOSIDASE INHIBITOR, INVERTASE INHIBITOR, AND SUGAR ABSORPTION INHIBITOR | Aug 2, 2020 | Abandoned |
Array
(
[id] => 16930734
[patent_doc_number] => 20210196623
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => NOVEL PARENTERAL CARBAMAZEPINE FORMULATION
[patent_app_type] => utility
[patent_app_number] => 16/939390
[patent_app_country] => US
[patent_app_date] => 2020-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8073
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 87
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16939390
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/939390 | NOVEL PARENTERAL CARBAMAZEPINE FORMULATION | Jul 26, 2020 | Abandoned |
Array
(
[id] => 17805791
[patent_doc_number] => 20220257626
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => TREATMENT COMPRISING SGLT INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/628857
[patent_app_country] => US
[patent_app_date] => 2020-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6436
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17628857
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/628857 | TREATMENT COMPRISING SGLT INHIBITORS | Jul 20, 2020 | Abandoned |
Array
(
[id] => 16397245
[patent_doc_number] => 20200338103
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-29
[patent_title] => HUMAN MILK OLIGOSACCHARIDES FOR MODULATING INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 16/927629
[patent_app_country] => US
[patent_app_date] => 2020-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16700
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16927629
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/927629 | HUMAN MILK OLIGOSACCHARIDES FOR MODULATING INFLAMMATION | Jul 12, 2020 | Abandoned |
Array
(
[id] => 17089751
[patent_doc_number] => 11117928
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-09-14
[patent_title] => Glycoconjugation process
[patent_app_type] => utility
[patent_app_number] => 16/923154
[patent_app_country] => US
[patent_app_date] => 2020-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 17759
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16923154
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/923154 | Glycoconjugation process | Jul 7, 2020 | Issued |